Logo
x

Search

Subscribe Now

two

Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

  • March 3, 2021
EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars

EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars

  • January 28, 2021
Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema

Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema

  • December 22, 2020
Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

  • October 28, 2020
Samsung Bioepis Reports Results of Renflexis (biosimilar- infliximab) from Two Studies in IBD Patients

Samsung Bioepis Reports Results of Renflexis (biosimilar- infliximab) from Two Studies in IBD Patients

  • October 27, 2020
Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies

Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies

  • September 10, 2020
Top 20 Innovative Digital Therapeutics Companies of 2024

    Top 20 Innovative Digital Therapeutics Companies of 2024

    • June 27, 2024
    4 Ways to Gain Experience Before Your Nursing Career Officially Starts

      4 Ways to Gain Experience Before Your Nursing Career Officially Starts

      • June 10, 2024
      Navigating the Path to Becoming a Healthcare Professional: Essential Tips for Students

        Navigating the Path to Becoming a Healthcare Professional: Essential Tips for Students

        • April 16, 2024
        Your Guide to Conference Coverage in the Healthcare Industry

          Your Guide to Conference Coverage in the Healthcare Industry

          • April 9, 2024
          Outlook Therapeutics’ Lytenana Gains the CHMP’s Positive Opinion for the Treatment of Wet AMD

            Outlook Therapeutics’ Lytenana Gains the CHMP’s Positive Opinion for the Treatment of Wet AMD

            • March 22, 2024
            Shionogi Reports the P-III Trial Results for Ensitrelvir as a Treatment of Common COVID-19 Symptoms

              Shionogi Reports the P-III Trial Results for Ensitrelvir as a Treatment of Common COVID-19 Symptoms

              • February 12, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.